Dose-dense weekly docetaxel and CBDCA in adriamycin-resistant metastatic breast cancer (MBC)

被引：5
|
作者：
Salimi, M [1 ]
Mir, MR [1 ]
机构：
[1] Mehr Hosp, Iranian Canc Inst, Tehran, Iran
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80167-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Treatment of metastatic breast cancer (MBC) with Vinorelbine and Docetaxel
    Savio, Giuseppina
    Leonardi, Vita
    Alu, Massimiliano
    Laudani, Agata
    Calabria, Caterina
    Scianna, Caterina
    Agostara, Biagio
    Ascoli, Maurizio
    ANNALS OF ONCOLOGY, 2004, 15 : 48 - 48
  • [22] Dose-Dense Nonpegylated Liposomal Doxorubicin and Docetaxel Combination in Breast Cancer: Dose-Finding Study
    Ricevuto, Enrico
    Cocciolone, Valentina
    Mancini, Maria
    Cannita, Katia
    Romano, Silvio
    Bruera, Gemma
    Pelliccione, Michela
    Adinolfi, Amaria Ilaria
    Ciccozzi, Antonietta
    Bafile, Alberto
    Penco, Maria
    Ficorella, Corrado
    ONCOLOGIST, 2015, 20 (02): : 109 - 110
  • [23] WEEKLY LOW-DOSE ADRIAMYCIN IN HORMONE-RESISTANT METASTATIC CANCER OF THE PROSTATE
    FOSSA, SD
    URNES, T
    KAALHUS, O
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1987, 21 (01): : 13 - 16
  • [24] Dose-dense chemotherapy for primary breast cancer
    Kuemmel, Sherko
    Rezai, Mahdi
    Kimmig, Rainer
    Schmid, Peter
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2007, 19 (01) : 75 - 81
  • [25] Dose-dense adjuvant chemotherapy for breast cancer
    Ziegler, JoAnne
    Citron, Marc
    CANCER NURSING, 2006, 29 (04) : 266 - 272
  • [26] Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide → dose-dense docetaxel
    Cocciolone, V.
    Tessitore, A.
    Ricevuto, E.
    Mastroiaco, V.
    Rinaldi, L.
    Paradisi, S.
    Irelli, A.
    Sidoni, T.
    Dal Mas, A.
    Coletti, G.
    Ciccozzi, A.
    Resta, V.
    Bafile, A.
    Alesse, E.
    Ficorella, C.
    Cannita, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S124 - S124
  • [27] Dose-dense chemotherapy in breast cancer and lymphoma
    Hudis, CA
    Schmitz, N
    SEMINARS IN ONCOLOGY, 2004, 31 (03) : 19 - 26
  • [28] Dose-dense therapy with paclitaxel via weekly 1-hour infusion: Preliminary experience in the treatment of metastatic breast cancer
    Seidman, AD
    Hudis, CA
    McCaffrey, J
    Tong, W
    Currie, V
    Moynahan, ME
    Theodoulou, M
    Tepler, I
    Gollub, M
    Norton, L
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 72 - 76
  • [29] Neoadjuvant, biweekly, dose-dense chemotherapy with epirubicin and cyclophoshamid followed by docetaxel in primary breast cancer
    Cramer, EM
    Moers, C
    Zarghooni, V
    Bosse, K
    Mallmann, P
    Warm, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S231 - S231
  • [30] The clinical utility of docetaxel in adriamycin resistant breast cancer
    Isamu Adachi
    Tetsuo Taguchi
    Breast Cancer, 1997, 4 (4) : 273 - 279
12345